Drug Shortage Report for APO-CANDESARTAN TABLETS

Last updated on 2025-03-07 History
Report ID 238233
Drug Identification Number 02541300
Brand name APO-CANDESARTAN TABLETS
Common or Proper name CANDESARTAN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) CANDESARTAN CILEXETIL
Strength(s) 16MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100 BTL
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-09-17
Estimated end date 2025-03-07
Actual end date 2025-03-06
Shortage status Resolved
Updated date 2025-03-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2025-03-07 French Compare
v17 2025-03-07 English Compare
v16 2025-02-27 French Compare
v15 2025-02-27 English Compare
v14 2025-01-30 French Compare
v13 2025-01-30 English Compare
v12 2025-01-09 French Compare
v11 2025-01-09 English Compare
v10 2024-12-12 French Compare
v9 2024-12-12 English Compare
v8 2024-11-28 French Compare
v7 2024-11-28 English Compare
v6 2024-10-17 French Compare
v5 2024-10-17 English Compare
v4 2024-10-04 French Compare
v3 2024-10-04 English Compare
v2 2024-09-20 French Compare
v1 2024-09-20 English Compare

Showing 1 to 18 of 18